Ma Kuang Healthcare Holding Limited (TPEX:4139)
Taiwan · Delayed Price · Currency is TWD 34.55
+3.10 (9.86%)
Jul 16, 2026, 1:18 PM CST
TPEX:4139 Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,083 | 1,093 | 1,130 | 1,218 | 1,059 | 959.45 | |
Revenue Growth (YoY) | -4.45% | -3.34% | -7.21% | 15.05% | 10.35% | 5.41% |
Cost of Revenue | 958.79 | 953.74 | 979.79 | 1,046 | 898.05 | 786.29 |
Gross Profit | 124.16 | 138.77 | 150.47 | 171.77 | 160.7 | 173.16 |
Selling, General & Admin | 127.65 | 128.11 | 123.91 | 128.69 | 108.22 | 107.69 |
Amortization of Goodwill & Intangibles | 1.24 | 1.23 | 1.24 | 1.18 | 1.14 | 1.13 |
Operating Expenses | 163.35 | 164.94 | 135.48 | 146.98 | 122.7 | 127.53 |
Operating Income | -39.18 | -26.17 | 14.99 | 24.79 | 37.99 | 45.64 |
Interest Expense | -37.78 | -38.4 | -44.38 | -43.33 | -26.72 | -22.47 |
Interest & Investment Income | 9.03 | 9.04 | 8.84 | 2.56 | 8.48 | 10.7 |
Earnings From Equity Investments | - | - | - | - | -23.95 | - |
Currency Exchange Gain (Loss) | -2.44 | -1.56 | -8.41 | 0.54 | -12.66 | -1.82 |
Other Non Operating Income (Expenses) | 7.54 | 9.51 | 46.16 | -6.38 | -7.74 | 29.75 |
EBT Excluding Unusual Items | -62.82 | -47.57 | 17.19 | -21.83 | -24.6 | 61.79 |
Impairment of Goodwill | -28.48 | -28.48 | -6.66 | -7.12 | -5.88 | -5.21 |
Gain (Loss) on Sale of Assets | 0.16 | -2.06 | -0.36 | 0.05 | -1.16 | - |
Other Unusual Items | 10.22 | 10.27 | 0.56 | 0.46 | 1.45 | - |
Pretax Income | -80.92 | -67.84 | 10.73 | -28.44 | -30.18 | 56.58 |
Income Tax Expense | 12.24 | 12.84 | 11.75 | 11.18 | 5.34 | 14.62 |
Earnings From Continuing Operations | -93.16 | -80.68 | -1.02 | -39.62 | -35.52 | 41.96 |
Minority Interest in Earnings | 14.12 | 13.6 | 11.3 | -2.91 | 4.62 | -3.42 |
Net Income | -79.04 | -67.08 | 10.28 | -42.53 | -30.9 | 38.54 |
Net Income to Common | -79.04 | -67.08 | 10.28 | -42.53 | -30.9 | 38.54 |
Net Income Growth | - | - | - | - | - | -50.05% |
Shares Outstanding (Basic) | 44 | 43 | 43 | 43 | 43 | 43 |
Shares Outstanding (Diluted) | 44 | 43 | 43 | 43 | 43 | 43 |
Shares Change (YoY) | 3.09% | 1.65% | - | - | -0.10% | -0.03% |
EPS (Basic) | -1.80 | -1.55 | 0.24 | -1.00 | -0.73 | 0.91 |
EPS (Diluted) | -1.80 | -1.55 | 0.24 | -1.00 | -0.73 | 0.90 |
EPS Growth | - | - | - | - | - | -50.28% |
Free Cash Flow | 215.38 | 213.81 | 313.48 | 162.95 | 48.04 | 191.77 |
Free Cash Flow Per Share | 4.91 | 4.94 | 7.37 | 3.83 | 1.13 | 4.50 |
Gross Margin | 11.46% | 12.70% | 13.31% | 14.10% | 15.18% | 18.05% |
Operating Margin | -3.62% | -2.40% | 1.33% | 2.04% | 3.59% | 4.76% |
Profit Margin | -7.30% | -6.14% | 0.91% | -3.49% | -2.92% | 4.02% |
Free Cash Flow Margin | 19.89% | 19.57% | 27.73% | 13.38% | 4.54% | 19.99% |
EBITDA | 1.86 | 15.9 | 59.04 | 66.19 | 69.54 | 72.18 |
EBITDA Margin | 0.17% | 1.46% | 5.22% | 5.43% | 6.57% | 7.52% |
D&A For EBITDA | 41.05 | 42.06 | 44.05 | 41.4 | 31.55 | 26.54 |
EBIT | -39.18 | -26.17 | 14.99 | 24.79 | 37.99 | 45.64 |
EBIT Margin | -3.62% | -2.40% | 1.33% | 2.04% | 3.59% | 4.76% |
Effective Tax Rate | - | - | 109.49% | - | - | 25.84% |